Pillstats
Rx only · Tablet, Film Coated · Oral

Rufinamide

Brands: Banzel · Rufinamide

7 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US13 NDCs
7 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
ATCN03AF03
RxCUI (US)69036
US makers7 labelers
Packages21
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 12 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$1.23$2.45$3.68$4.90Dec 2025Apr 2026Jul 2026
$4.098
Latest avg · Jul 22, 2026
-4%
Since Dec 17, 2025
7
Active US suppliers
43%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

4.8K9.6K14K19K2025 Q12025 Q22025 Q32025 Q42026 Q1
16K
Rx · 2026 Q1
2.6M
Units dispensed
-6%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it7 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Glenmark Pharmaceuticals Inc., USAunknown5SUPPLYING
Camber Pharmaceuticals, Inc.unknown4SUPPLYING
Eisai Inc.unknown4SUPPLYING
Pharma Packaging Solutions, LLC dba Tjoapack LLCunknown2SUPPLYING
Lupin Pharmaceuticals,Inc.unknown2SUPPLYING
Hikma Pharmaceuticals USA Inc.unknown2SUPPLYING
Aurobindo Pharma Limitedunknown2SUPPLYING

Regulatory & supply eventsFDA · US

Shortages, recalls, and registration changes attached to this drug concept.

  • Mar 13, 2025
    RECALLRecall (Class II): Rufinamide Tablets 200mg, 120-count bottle, Rx Only, Manufactured by: Glenmark Pharmaceuticals Limited, Pithampur, Madh…

    CGMP Deviations — Recalling firm: Glenmark Pharmaceuticals Inc., USA — U.S. Nationwide

  • Jul 21, 2023
    RECALLRecall (Class II): Rufinamide Tablets, USP 400 mg, packaged in 120-count bottle, Rx only, Distributed by: Aurobindo Pharma USA, Inc., 279…

    cGMP deviations: Batch was released prior to approval. — Recalling firm: Aurobindo Pharma USA Inc. — USA nationwide

  • Jul 21, 2023
    RECALLRecall (Class II): Rufinamide Tablets, USP 200 mg, packaged in 120-count bottle, Rx only, Distributed by: Aurobindo Pharma USA, Inc., 279…

    cGMP deviations: Batch was released prior to approval. — Recalling firm: Aurobindo Pharma USA Inc. — USA nationwide

  • Mar 15, 2021
    RECALLRecall (Class II): Banzel (rufinamide) tablets 200 mg 120 tablets Rx only NDC 62856-582-52 Manufactured by Eisai Co., Ltd. Marketed by Eis…

    CGMP Deviations: Intermittent exposure to temperature excursion during storage. — Recalling firm: Cardinal Health Inc. — FL, GA, SC